Group Refutes Touted Savings of Ohio Drug Price Relief Act


This week, Ohioans Against the Deceptive Rx Ballot Issue issued a news release refuting the cost-savings claims contained in the so-called Ohio Drug Price Relief Act. The November statewide ballot initiative, if passed, would add a new requirement to Ohio law that a range of state government related entities, including the Ohio Medicaid program, pay no more for prescription drugs than is paid by the U.S. Department of Veterans Affairs. A cost analysis performed by former state budget director Greg Browning disproves claims made by proponents that the issue would reduce costs. In his analysis, Browning refers to those claims as “false and without merit.” The OMA opposes the measure and supports the Ohioans Against the Deceptive Rx Ballot Issue campaign. 7/19/2017